Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.

Standard

Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. / Fonseca, Tatiana L; Jorgetti, Vanda; Costa, Cristiane C; Capelo, Luciane P; Covarrubias, Ambart E; Moulatlet, Ana C; Teixeira, Marilia B; Hesse, Eric; Morethson, Priscilla; Beber, Eduardo H; Freitas, Fatima R; Wang, Charles C; Nonaka, Keico O; Oliveira, Ricardo; Casarini, Dulce E; Zorn, Telma M; Brum, Patricia C; Gouveia, Cecilia H.

In: J BONE MINER RES, Vol. 26, No. 3, 3, 2011, p. 591-603.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Fonseca, TL, Jorgetti, V, Costa, CC, Capelo, LP, Covarrubias, AE, Moulatlet, AC, Teixeira, MB, Hesse, E, Morethson, P, Beber, EH, Freitas, FR, Wang, CC, Nonaka, KO, Oliveira, R, Casarini, DE, Zorn, TM, Brum, PC & Gouveia, CH 2011, 'Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.', J BONE MINER RES, vol. 26, no. 3, 3, pp. 591-603. <http://www.ncbi.nlm.nih.gov/pubmed/20814988?dopt=Citation>

APA

Fonseca, T. L., Jorgetti, V., Costa, C. C., Capelo, L. P., Covarrubias, A. E., Moulatlet, A. C., Teixeira, M. B., Hesse, E., Morethson, P., Beber, E. H., Freitas, F. R., Wang, C. C., Nonaka, K. O., Oliveira, R., Casarini, D. E., Zorn, T. M., Brum, P. C., & Gouveia, C. H. (2011). Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. J BONE MINER RES, 26(3), 591-603. [3]. http://www.ncbi.nlm.nih.gov/pubmed/20814988?dopt=Citation

Vancouver

Fonseca TL, Jorgetti V, Costa CC, Capelo LP, Covarrubias AE, Moulatlet AC et al. Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. J BONE MINER RES. 2011;26(3):591-603. 3.

Bibtex

@article{9939bc334b9648a18c07e6f4b1bb751b,
title = "Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.",
abstract = "Evidence demonstrates that sympathetic nervous system (SNS) activation causes osteopenia via ?(2)-adrenoceptor (?2-AR) signaling. Here we show that female mice with chronic sympathetic hyperactivity owing to double knockout of adrenoceptors that negatively regulate norepinephrine release, ?(2A)-AR and ?(2C)-AR (?(2A) /?(2C)-ARKO), present an unexpected and generalized phenotype of high bone mass with decreased bone resorption and increased formation. In ?(2A) /?(2C)-ARKO versus wild-type (WT) mice, micro-computed tomographic (µCT) analysis showed increased, better connected, and more plate-shaped trabeculae in the femur and vertebra and increased cortical thickness in the vertebra, whereas biomechanical analysis showed increased tibial and femoral strength. Tibial mRNA expression of tartrate-resistant acid phosphatase (TRACP) and receptor activator of NF-?B (RANK), which are osteoclast-related factors, was lower in knockout (KO) mice. Plasma leptin and brain mRNA levels of cocaine amphetamine-regulated transcript (CART), which are factors that centrally affect bone turnover, and serum levels of estradiol were similar between mice strains. Tibial ?(2)-AR mRNA expression also was similar in KO and WT littermates, whereas ?(2A)-, ?(2B)- and ?(2C)-AR mRNAs were detected in the tibia of WT mice and in osteoblast-like MC3T3-E1 cells. By immunohistochemistry, we detected ?(2A)-, ?(2B)-, ?(2C)- and ?(2)-ARs in osteoblasts, osteoclasts, and chondrocytes of 18.5-day-old mouse fetuses and 35-day-old mice. Finally, we showed that isolated osteoclasts in culture are responsive to the selective ?(2)-AR agonist clonidine and to the nonspecific ?-AR antagonist phentolamine. These findings suggest that ?(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that ?(2)-AR signaling also may mediate the SNS actions in the skeleton.",
keywords = "Animals, Female, Mice, Mice, Knockout, Phenotype, Osteogenesis/drug effects, Adrenergic alpha-2 Receptor Agonists/pharmacology, Bone Resorption/blood/complications/genetics, Bone and Bones/drug effects/metabolism/*pathology, Brain/drug effects/metabolism, Estradiol/blood, *Gene Deletion, Gene Expression Regulation/drug effects, Hyperkinesis/blood/complications/*pathology, Leptin/blood, Myocardium/metabolism, Nerve Tissue Proteins/metabolism, Norepinephrine/blood, Organ Size/drug effects, Osteoclasts/drug effects/pathology, Receptors, Adrenergic, alpha-2/*metabolism, Sympathetic Nervous System/drug effects/*pathology, Animals, Female, Mice, Mice, Knockout, Phenotype, Osteogenesis/drug effects, Adrenergic alpha-2 Receptor Agonists/pharmacology, Bone Resorption/blood/complications/genetics, Bone and Bones/drug effects/metabolism/*pathology, Brain/drug effects/metabolism, Estradiol/blood, *Gene Deletion, Gene Expression Regulation/drug effects, Hyperkinesis/blood/complications/*pathology, Leptin/blood, Myocardium/metabolism, Nerve Tissue Proteins/metabolism, Norepinephrine/blood, Organ Size/drug effects, Osteoclasts/drug effects/pathology, Receptors, Adrenergic, alpha-2/*metabolism, Sympathetic Nervous System/drug effects/*pathology",
author = "Fonseca, {Tatiana L} and Vanda Jorgetti and Costa, {Cristiane C} and Capelo, {Luciane P} and Covarrubias, {Ambart E} and Moulatlet, {Ana C} and Teixeira, {Marilia B} and Eric Hesse and Priscilla Morethson and Beber, {Eduardo H} and Freitas, {Fatima R} and Wang, {Charles C} and Nonaka, {Keico O} and Ricardo Oliveira and Casarini, {Dulce E} and Zorn, {Telma M} and Brum, {Patricia C} and Gouveia, {Cecilia H}",
year = "2011",
language = "English",
volume = "26",
pages = "591--603",
journal = "J BONE MINER RES",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.

AU - Fonseca, Tatiana L

AU - Jorgetti, Vanda

AU - Costa, Cristiane C

AU - Capelo, Luciane P

AU - Covarrubias, Ambart E

AU - Moulatlet, Ana C

AU - Teixeira, Marilia B

AU - Hesse, Eric

AU - Morethson, Priscilla

AU - Beber, Eduardo H

AU - Freitas, Fatima R

AU - Wang, Charles C

AU - Nonaka, Keico O

AU - Oliveira, Ricardo

AU - Casarini, Dulce E

AU - Zorn, Telma M

AU - Brum, Patricia C

AU - Gouveia, Cecilia H

PY - 2011

Y1 - 2011

N2 - Evidence demonstrates that sympathetic nervous system (SNS) activation causes osteopenia via ?(2)-adrenoceptor (?2-AR) signaling. Here we show that female mice with chronic sympathetic hyperactivity owing to double knockout of adrenoceptors that negatively regulate norepinephrine release, ?(2A)-AR and ?(2C)-AR (?(2A) /?(2C)-ARKO), present an unexpected and generalized phenotype of high bone mass with decreased bone resorption and increased formation. In ?(2A) /?(2C)-ARKO versus wild-type (WT) mice, micro-computed tomographic (µCT) analysis showed increased, better connected, and more plate-shaped trabeculae in the femur and vertebra and increased cortical thickness in the vertebra, whereas biomechanical analysis showed increased tibial and femoral strength. Tibial mRNA expression of tartrate-resistant acid phosphatase (TRACP) and receptor activator of NF-?B (RANK), which are osteoclast-related factors, was lower in knockout (KO) mice. Plasma leptin and brain mRNA levels of cocaine amphetamine-regulated transcript (CART), which are factors that centrally affect bone turnover, and serum levels of estradiol were similar between mice strains. Tibial ?(2)-AR mRNA expression also was similar in KO and WT littermates, whereas ?(2A)-, ?(2B)- and ?(2C)-AR mRNAs were detected in the tibia of WT mice and in osteoblast-like MC3T3-E1 cells. By immunohistochemistry, we detected ?(2A)-, ?(2B)-, ?(2C)- and ?(2)-ARs in osteoblasts, osteoclasts, and chondrocytes of 18.5-day-old mouse fetuses and 35-day-old mice. Finally, we showed that isolated osteoclasts in culture are responsive to the selective ?(2)-AR agonist clonidine and to the nonspecific ?-AR antagonist phentolamine. These findings suggest that ?(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that ?(2)-AR signaling also may mediate the SNS actions in the skeleton.

AB - Evidence demonstrates that sympathetic nervous system (SNS) activation causes osteopenia via ?(2)-adrenoceptor (?2-AR) signaling. Here we show that female mice with chronic sympathetic hyperactivity owing to double knockout of adrenoceptors that negatively regulate norepinephrine release, ?(2A)-AR and ?(2C)-AR (?(2A) /?(2C)-ARKO), present an unexpected and generalized phenotype of high bone mass with decreased bone resorption and increased formation. In ?(2A) /?(2C)-ARKO versus wild-type (WT) mice, micro-computed tomographic (µCT) analysis showed increased, better connected, and more plate-shaped trabeculae in the femur and vertebra and increased cortical thickness in the vertebra, whereas biomechanical analysis showed increased tibial and femoral strength. Tibial mRNA expression of tartrate-resistant acid phosphatase (TRACP) and receptor activator of NF-?B (RANK), which are osteoclast-related factors, was lower in knockout (KO) mice. Plasma leptin and brain mRNA levels of cocaine amphetamine-regulated transcript (CART), which are factors that centrally affect bone turnover, and serum levels of estradiol were similar between mice strains. Tibial ?(2)-AR mRNA expression also was similar in KO and WT littermates, whereas ?(2A)-, ?(2B)- and ?(2C)-AR mRNAs were detected in the tibia of WT mice and in osteoblast-like MC3T3-E1 cells. By immunohistochemistry, we detected ?(2A)-, ?(2B)-, ?(2C)- and ?(2)-ARs in osteoblasts, osteoclasts, and chondrocytes of 18.5-day-old mouse fetuses and 35-day-old mice. Finally, we showed that isolated osteoclasts in culture are responsive to the selective ?(2)-AR agonist clonidine and to the nonspecific ?-AR antagonist phentolamine. These findings suggest that ?(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that ?(2)-AR signaling also may mediate the SNS actions in the skeleton.

KW - Animals

KW - Female

KW - Mice

KW - Mice, Knockout

KW - Phenotype

KW - Osteogenesis/drug effects

KW - Adrenergic alpha-2 Receptor Agonists/pharmacology

KW - Bone Resorption/blood/complications/genetics

KW - Bone and Bones/drug effects/metabolism/pathology

KW - Brain/drug effects/metabolism

KW - Estradiol/blood

KW - Gene Deletion

KW - Gene Expression Regulation/drug effects

KW - Hyperkinesis/blood/complications/pathology

KW - Leptin/blood

KW - Myocardium/metabolism

KW - Nerve Tissue Proteins/metabolism

KW - Norepinephrine/blood

KW - Organ Size/drug effects

KW - Osteoclasts/drug effects/pathology

KW - Receptors, Adrenergic, alpha-2/metabolism

KW - Sympathetic Nervous System/drug effects/pathology

KW - Animals

KW - Female

KW - Mice

KW - Mice, Knockout

KW - Phenotype

KW - Osteogenesis/drug effects

KW - Adrenergic alpha-2 Receptor Agonists/pharmacology

KW - Bone Resorption/blood/complications/genetics

KW - Bone and Bones/drug effects/metabolism/pathology

KW - Brain/drug effects/metabolism

KW - Estradiol/blood

KW - Gene Deletion

KW - Gene Expression Regulation/drug effects

KW - Hyperkinesis/blood/complications/pathology

KW - Leptin/blood

KW - Myocardium/metabolism

KW - Nerve Tissue Proteins/metabolism

KW - Norepinephrine/blood

KW - Organ Size/drug effects

KW - Osteoclasts/drug effects/pathology

KW - Receptors, Adrenergic, alpha-2/metabolism

KW - Sympathetic Nervous System/drug effects/pathology

M3 - SCORING: Journal article

VL - 26

SP - 591

EP - 603

JO - J BONE MINER RES

JF - J BONE MINER RES

SN - 0884-0431

IS - 3

M1 - 3

ER -